PRESS RELEASE Stockholm, February 16, 2006 MedAssets Supply Chain Systems, one of the fastest growing group purchasing organizations (GPO) in the U.S., has signed a contract with Elekta, Inc. and IMPAC Medical Systems, Inc., an Elekta company, for radiation oncology treatment products and IMPAC’s oncology-specific healthcare IT solutions.

MedAssets is the first GPO to sign a joint Elekta/IMPAC contract since the companies combined in 2005. The contract includes the revolutionary Elekta Synergy® treatment delivery series and the MOSAIQ™ product spectrum from IMPAC. In addition, MedAssets has a contract with Elekta for stereotactic neurosurgical products, including Leksell Gamma Knife®. “We continually seek ways to offer our customers the best contracts and opportunities available, and we can do that through our relationship with Elekta,” stated Jerry Allen, Director of Radiology and Cardiovascular Services, MedAssets Supply Chain Systems. The MedAssets contract continues Elekta’s strong relationships within the GPO market space. A majority of the top 10 healthcare group purchasing organizations in the U.S. now have provider contracts with Elekta for radiation oncology, stereotactic radiosurgery and associated neuroscience products. “Hospital systems face intense pressure to maintain a competitive edge, both in terms of obtaining patient referrals and in attracting and retaining top-notch clinical staff,” said Anthony De Carolis, President and CEO of Elekta, Inc. and head of the U.S. operations of the Elekta Group. “Elekta’s proven, leading-edge clinical solutions offer hospitals and clinics the opportunity to both provide a higher level of patient care and to grow their business within the communities they serve.” “The customers of MedAssets will be among the first in the United States to benefit from the close collaboration and joint development between Elekta and IMPAC,” said Jay Hoey, CEO of IMPAC. “IMPAC’s oncology-specific healthcare IT solutions fully integrate with Elekta’s radiation oncology treatment solutions to improve patient outcomes and expedite workflow, benefiting both the patient and the treatment center.” ******

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com


Documents & Links